Apellis Pharmaceuticals, Inc.

NasdaqGS:APLS Voorraadrapport

Marktkapitalisatie: US$3.4b

Apellis Pharmaceuticals Eigendom

Wie zijn de grootste aandeelhouders en hebben insiders gekocht of verkocht?

Recente transacties met voorkennis

NasdaqGS:APLS Recente transacties met voorkennis door bedrijven of personen
DatumWaardeNaamEntiteitRolAandelenMaximale prijs
16 Sep 24SellUS$6,952James ChopasIndividual192US$36.21
03 Sep 24SellUS$21,720James ChopasIndividual550US$39.49
19 Mar 24SellUS$1,068,161Epidarex CapitalCompany18,681US$57.18
18 Mar 24SellUS$564,050Mark DelongIndividual9,913US$56.90
15 Mar 24SellUS$10,389James ChopasIndividual184US$56.46
13 Mar 24SellUS$645,838Nur NicholsonIndividual11,220US$58.13
12 Feb 24SellUS$40,457Mark DelongIndividual597US$67.77
12 Feb 24SellUS$96,974Timothy SullivanIndividual1,431US$67.77
12 Feb 24SellUS$77,796Adam TownsendIndividual1,148US$67.77
12 Feb 24SellUS$52,926David WatsonIndividual781US$67.77
12 Feb 24SellUS$268,492Cedric FrancoisIndividual3,962US$67.77
12 Feb 24SellUS$77,796Pascal DeschateletsIndividual1,148US$67.77
29 Jan 24SellUS$23,539Mark DelongIndividual367US$64.14
29 Jan 24SellUS$17,895Jeffrey EiseleIndividual279US$64.14
29 Jan 24SellUS$182,345Cedric FrancoisIndividual2,843US$64.14
29 Jan 24SellUS$56,057Pascal DeschateletsIndividual874US$64.14
29 Jan 24SellUS$58,109Adam TownsendIndividual906US$64.14
29 Jan 24SellUS$58,109David WatsonIndividual906US$64.14
29 Jan 24SellUS$53,555Nur NicholsonIndividual835US$64.14
29 Jan 24SellUS$58,109Timothy SullivanIndividual906US$64.14
29 Jan 24SellUS$23,539Karen LewisIndividual367US$64.14
22 Jan 24SellUS$254,329Pascal DeschateletsIndividual3,913US$65.00
22 Jan 24SellUS$221,831Adam TownsendIndividual3,413US$65.00
22 Jan 24SellUS$271,943David WatsonIndividual4,184US$65.00
22 Jan 24SellUS$112,963Karen LewisIndividual1,738US$65.00
22 Jan 24SellUS$168,535Nur NicholsonIndividual2,593US$65.00
22 Jan 24SellUS$230,801Timothy SullivanIndividual3,551US$65.00
22 Jan 24SellUS$89,954Mark DelongIndividual1,384US$65.00
22 Jan 24SellUS$68,961James ChopasIndividual1,061US$65.00
22 Jan 24SellUS$104,449Jeffrey EiseleIndividual1,607US$65.00
22 Jan 24SellUS$872,961Cedric FrancoisIndividual13,431US$65.00
16 Jan 24SellUS$524,514Cedric FrancoisIndividual7,851US$66.81
16 Jan 24SellUS$109,032Karen LewisIndividual1,632US$66.81
16 Jan 24SellUS$149,317Timothy SullivanIndividual2,235US$66.81
16 Jan 24SellUS$124,064Nur NicholsonIndividual1,857US$66.81
16 Jan 24SellUS$109,032Pascal DeschateletsIndividual1,632US$66.81
16 Jan 24SellUS$149,317Adam TownsendIndividual2,235US$66.81
16 Jan 24SellUS$283,268David WatsonIndividual4,240US$66.81
16 Jan 24SellUS$29,262Jeffrey EiseleIndividual438US$66.81
16 Jan 24SellUS$108,965Mark DelongIndividual1,631US$66.81
16 Jan 24SellUS$57,723James ChopasIndividual864US$66.81
04 Jan 24SellUS$165,207Caroline BaumalIndividual2,751US$60.05
26 Dec 23SellUS$3,935Jeffrey EiseleIndividual68US$57.86
01 Dec 23SellUS$1,467,240Epidarex CapitalCompany24,000US$61.14
21 Nov 23SellUS$244,000Cedric FrancoisIndividual5,000US$48.80
17 Nov 23SellUS$444,620A. DunlopIndividual8,894US$49.99

Volume handel met voorkennis

Insider-aankopen: APLS insiders hebben de afgelopen 3 maanden alleen aandelen verkocht.

Opsplitsing eigendom

Wat is de eigendomsstructuur van APLS?
Type eigenaarAantal AandelenEigendomspercentage
Staat of regering45.4450,0333%
Individuele insiders4.183.4883,07%
VC/PE-bedrijven12.806.3429,39%
Hedgefondsen22.718.53616,6%
Instellingen96.698.03670,9%

Verwatering van aandelen: De aandeelhouders zijn het afgelopen jaar verwaterd, waarbij het totale aantal uitstaande aandelen met 2.8% is gegroeid.

Topaandeelhouders

Top 25 aandeelhouders bezitten 91.49% van het bedrijf
EigendomNaamAandelenHuidige waardeVerandering %Portefeuille %
13,5%
Wellington Management Group LLP
16.388.697US$458.6m8,84%0,07%
10,5%
The Morningside Group Limited
12.806.342US$358.3m0%80,5%
9,53%
EcoR1 Capital, LLC
11.607.425US$324.8m2,2%10,48%
9,12%
Avoro Capital Advisors LLC
11.111.111US$310.9m0%3,84%
8,06%
The Vanguard Group, Inc.
9.809.552US$274.5m3,19%geen gegevens
5,09%
BlackRock, Inc.
6.191.937US$173.3m6,84%geen gegevens
4,37%
T. Rowe Price Group, Inc.
5.324.838US$149.0m-24,6%0,01%
3,41%
State Street Global Advisors, Inc.
4.146.694US$116.0m42,5%geen gegevens
2,95%
Jennison Associates LLC
3.591.416US$100.5m10,8%0,06%
2,71%
FMR LLC
3.299.742US$92.3m51,5%0,01%
2,57%
JP Morgan Asset Management
3.131.953US$87.6m46,9%0,01%
2,37%
Octagon Capital Advisors LP
2.880.880US$80.6m2,63%12,06%
2,05%
Deep Track Capital, LP
2.500.000US$69.9m150%1,77%
1,76%
Assenagon Asset Management S.A.
2.144.415US$60.0m192%0,11%
1,66%
Morgan Stanley, Investment Banking and Brokerage Investments
2.016.220US$56.4m34,2%0,01%
1,49%
Deutsche Asset & Wealth Management
1.819.604US$50.9m14,2%0,01%
1,47%
Geode Capital Management, LLC
1.787.917US$50.0m5,8%geen gegevens
1,42%
Tavistock Life Sciences
1.726.000US$48.3m0%3,04%
1,41%
Cedric Francois
1.711.187US$47.9m-6,71%geen gegevens
1,2%
Artal Group S.A.
1.467.080US$41.0m11,5%0,91%
1,11%
Fiera Capital Corporation
1.354.469US$37.9m-3,33%0,09%
1,07%
OrbiMed Advisors LLC
1.302.800US$36.5m0,39%0,48%
0,91%
Pascal Deschatelets
1.113.897US$31.2m2,48%geen gegevens
0,89%
Invesco Ltd.
1.084.514US$30.3m44,8%0,01%
0,89%
Norges Bank Investment Management
1.079.605US$30.2m14,1%geen gegevens